耐力训练和急性力竭运行对大鼠组织金属硫蛋白含量的不同…

为探讨金属硫蛋白（ＭＴ）在运动提高机体自我贩作用,本文实验观察了游泳运动对大鼠心、肝、肺、脑、血管、因浆和骨骼肌等组织金属硫蛋白含量的影响。结果表明耐力训练组大鼠心、肝、肺和骨骼组织金属硫蛋白含量较政党对照组明显降低１３－３４％（Ｐ〈０．０５）;急性力竭运动组大鼠心、肝、脑、肺和骨骼肌组织其含量较正常对照则明显或高２１－７５％（Ｐ〈０．０５）;但两组大鼠血管和血浆ＭＴ含量变化与对照组大鼠要比无统计     

猪圆环病毒2型流行株的分离及其感染性克隆的构建

【目的】通过分离一株猪圆环病毒2型(PCV2)流行毒株,并构建其感染性克隆,为研究PCV2基因功能提供操作平台。【方法】通过PCR方法,从疑似患断奶仔猪多系统衰竭综合症(PMWS)的仔猪淋巴结中鉴定为猪圆环病毒(Porcine circovirus,PCV)2型阳性。把阳性病料接种PK-15细胞传代培养,在培养物中扩增出PCV2的全基因序列。对扩增出的全序列进行序列测定,并与GenBank中公布的5株广东PCV2分离株(GD-pz、GD-gj、GD-jm、GD-ss和GD-sz)进行同源性分析。通过EcoRⅠ和SalⅠ将PCV2全基因组序列克隆进pUC18载体中,获得含PCV2 GD-zq株全基因组单拷贝的重组质粒pPCV2-GD-zq,再通过SalⅠ和HindⅢ把另一个全长拷贝克隆进pPCV2-GD-zq质粒中,使PCV2 GD-zq株基因组DNA以头尾相接的双重复方式克隆进pUC18载体中,获得重组质粒pPCV2-2GD-zq。将pPCV2-2GD-zq DNA纯化和定量后转染PK-15细胞,拯救PCV2 GD-zq病毒。【结果】从PMWS感染的猪淋巴结中分离到了一株PCV2,命名为GD-zq株;序列分析结果显示,GD-zq株全基因组为1 767 bp,与GenBank中公布的5株广东PCV2分离株ORF1核苷酸一致性为97.1%-99.7%,编码氨基酸一致性为98.7%-100%;ORF2核苷酸一致性为93.2%-99.6%,编码氨基酸一致性为92.3%-99.1%;全基因一致性为96.0%-99.6%。pPCV2-2GD-zq质粒转染PK-15细胞后,其通过间接免疫荧光实验(IFA)能从转染细胞及其传代细胞中,检测到拯救出的病毒。【结论】分离了一株PCV2广东株GD-zq,成功构建了PCV2 GD-zq株的感染性克隆。     

一株芝麻香型白酒高温大曲的施莱格尔氏菌的分离与鉴定

从芝麻香型白酒高温大曲中分离到一株革兰氏阴性高温细菌Zm91,并对其进行形态学、生理生化代谢特征以及细胞代谢酶活性和药物敏感性分析,结合16S rRNA基因序列分析结果,Zm91鉴定为水生施莱格尔氏菌(Schlegelella aquatica).该菌株是首次从我国芝麻香型白酒高温大曲中分离得到的施莱格尔氏菌,其G+C mol％含量为67.5％,具有碱性磷酸盐酶、酯酶(C4)、脂酯酶(C8)、白氨酸芳胺酶、颉氨酸芳胺酶、胰凝乳蛋白酶、萘酚-AS-BI-磷酸水解酶及α葡萄糖苷酶活性,对青霉素、氨苄西林、链霉素、利福平敏感.     

Mitochondrial DNA polymorphisms in subterranean mole-rats of the Spalax ehrenbergi superspecies in Israel, and its peripheral isolates

Patterns of mitochondrial DNA (mtDNA) variation were examined in 133 mole-rats constituting all four chromosomal species (2n = 52, 2n = 54, 2n = 58, and 2n = 60) of the Spalax ehrenbergi superspecies in Israel, as well as the peripheral isolates of 2n = 60. In the main range of the complex, a total of 28 mtDNA haplotypes were found in 64 mole-rats, with most haplotypes being unique to either a single chromosomal species or population. mtDNA divergence increased from low to high diploid number in a north-to-south direction in Israel. Overall levels of mtDNA diversity were unexpectedly the highest in the 2n = 60, the youngest species of the complex. The mtDNA haplotypes can be separated into two major groups, 2n = 52-54 and 2n = 58-60, and a phylogenetic analysis for each group revealed evidence of a few haplotypes not sorted by diploid number. The overall patterns of mtDNA divergence seen within and among the four chromosomal species are consistent with the parapatric mode of speciation as suggested from previous studies of allozyme and DNA hybridization. In a separate data set the patterns of mtDNA variation were examined across the main geographic range and across peripheral semi-isolates and isolates of the 2n = 60 chromosomal species. Fifteen haplotypes were found in 69 mole-rats. High levels of mtDNA diversity characterized the main range, semi-isolated, and even some desert isolated populations. The peripheral isolates contain much mtDNA diversity, including novel haplotypes.      

Hepatoprotective effect of Herpetospermum caudigerum Wall. on carbon tetrachloride‐induced hepatic fibrosis in rats

Tibetan medicine Herpetospermum caudigerum Wall. (HCW) has long been employed to treat hepatitis, inflammatory diseases and jaundice according to the records of “The Four Medical Tantras” in China. This study was investigated to explore the protective effects of HCW on hepatic fibrosis and the possible mechanism in a rat model. Hepatic fibrosis was established by intragastric administration of 3 ml/kg carbon tetrachloride (CCl₄) twice a week for 6 weeks. CCl₄‐treated rats were received HCW (1 and 3 g/kg/d) and silymarin (0.1 g/kg/d) from 3 to 6 weeks. The results showed that HCW could significantly decrease the levels of AST, ALT, HA, LN, PCIII, Col IV, TNF‐α, IL‐1β and IL‐6. Moreover, HCW could effectively inhibit collagen deposition and reduce the pathological damage. Analysis experiments finally exhibited that HCW was able to markedly inhibit hepatic fibrosis by modulating the expressions of NF‐κB p65, IκBα, Samd3 and TGF‐β1 proteins. Therefore, our results suggest that HCW has hepatoprotective activity against CCl₄‐induced hepatic fibrosis in rats by regulating the inflammatory responses.     

A real-world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy or failed in previous amoxicillin-containing therapies

Background

The treatment of Helicobacter pylori (H. pylori) infection is a challenge for those who cannot use amoxicillin.

Objective

To evaluate the eradication rate and adverse effects of vonoprazan and tetracycline dual therapy as first-line and rescue treatment regimens used in special populations with penicillin allergy or failed in previous amoxicillin-containing therapies.

Design

Patients enrolled were those who were H. pylori-positive with selected conditions: (1) allergic to penicillin, either naïve to treatment or had failed before; or (2) failed in previous amoxicillin-containing therapies. All enrolled patients accepted 14-day vonoprazan and tetracycline dual therapy (VT dual therapy) as follows: vonoprazan (20 mg b.i.d.) and tetracycline (500 mg t.i.d. [body weight < 70 kg] or 500 mg q.i.d. [body weight ≥ 70 kg]). H. pylori status was evaluated by ¹³C-urease breath test 6 weeks after treatment. All adverse effects were recorded. Some patients underwent bacterial culture and antibiotic susceptibility testing.

Results

A total of 62 patients were enrolled; 18 of them received VT dual therapy as first-line treatment, 44 patients received VT dual therapy as rescue treatment. Overall, 58 of 62 patients achieved successful eradication (93.5%), while all involved (100%,18/18) succeeded in the first-line treatment group and 40 cases (90.9%, 40/44) succeeded in the rescue treatment group. Sixty-one (61/62, 98.4%) patients completed the whole course of treatment. Adverse events occurred in 6 patients (6/62, 9.7%), while one patient quit because of skin rash. All adverse effects were mild and relieved spontaneously after H. pylori treatment. Five patients achieved successful H. pylori culture, and all strains isolated were sensitive to tetracycline.

Conclusions

For the treatment of H. pylori infection in special populations with penicillin allergy or failed in previous amoxicillin-containing therapies, a 14-day vonoprazan and tetracycline dual therapy was effective and safe as first-line and rescue treatment in our study. Further study is warranted to verify its efficacy, especially for those who cannot use amoxicillin.     

帝萝花‘璀璨明珠'的植株高效再生

为解决木本切花植物帝萝花‘璀璨明珠’繁殖效率低的问题,该文以帝萝花‘璀璨明珠’的幼嫩枝芽为外植体,研究了不同基本培养基对其长势的影响、不同激素种类和浓度对其增殖和生根的效果,分析了其离体繁殖的生长特点,并建立了高效的帝萝花‘璀璨明珠’组培快繁技术体系。结果表明:帝萝花‘璀璨明珠’幼嫩枝芽的消毒方法为0.1%的升汞溶液浸泡12 min,污染率为21.5%;外植体在WPM+ZT 1 mg·L~(-1)+NAA 0.1 mg·L~(-1)培养基上,侧芽萌发率为73%;增殖的最佳培养基为MS+BA 0.4 mg·L~(-1)+NAA 0.05 mg·L~(-1),增殖系数为6.63,增殖方式为侧芽增殖和植株基部丛生芽增殖;生根的适宜培养基为MS+IBA 0.75mg·L~(-1)+NAA 1 mg·L~(-1),生根率为70%;生根瓶苗移栽于珍珠岩和细草炭(体积比为0.5∶1)的基质中,光照强度为10 000～12 000 lx,空气湿度为70%～80%下培养,60 d后成活率可达72%。该研究结果为帝萝花组培种苗的商业化生产提供了技术支撑,同时促进了该高档木本切花的推广和种植及产业化。     

响应面法优化黑曲霉HDF05产β-葡萄糖苷酶过程参数

为获得黑曲霉Aspergillus niger HDF05菌株较高的β-葡萄糖苷酶酶活,对其发酵条件进行了优化。采用Plackett-Burman实验设计考察关键发酵操作参数对产酶的影响。继而采用最陡爬坡路径逼近最大响应区域,并结合中心组合实验和响应面对4个显著性因素进行分析。Plackett-Burman实验结果表明,发酵温度、装液量、麦麸和 (NH4)2SO4浓度对β-葡萄糖苷酶合成影响显著。通过响应面分析得到一元二阶方程,对方程求解得到优化的发酵过程参数：发酵温度为28 ℃,装液量为71.4 mL/250 mL,麸皮浓度为36 g/L,(NH4)2SO4浓度为5.5 g/L。采用该优化的过程参数,菌株的最大产β-葡萄糖苷酶活力可达60.06 U/mL,较优化前提高了23.9％。将黑曲霉HDF05产生的β-葡萄糖苷酶用于酸解玉米芯纤维残渣的酶解实验中,可明显降低纤维二糖的积累,48 h内可使玉米芯纤维素残渣酶解得率达到80.4％。